Biosimilar structural comparability assessment by NMR: from small proteins to monoclonal antibodies. [electronic resource]
- Scientific reports 08 2016
- 32201 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/srep32201 doi
Biosimilar Pharmaceuticals--chemistry Filgrastim--chemistry Nuclear Magnetic Resonance, Biomolecular Rituximab--chemistry